secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTERPACE BIOSCIENCES, INC. (IDXG)
CIK:        0001054102
Form:       8-K
Filed at:   2021-10-19T23:59:59+00:00
Accession:  0001493152-21-025744
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Interpace Biosciences enters $7.5M revolving credit facility with Comerica Bank
-------------------------------------------------------------------------------

- Credit facility of up to $7.5M, matures September 30, 2023, secured by substantially all assets.
- Advances based on 80% of eligible accounts receivable plus $2M non-formula availability stepping down $250K/quarter.
- Interest rate equals prime plus 0.50% (prime is greater of Comerica's rate or daily LIBOR + 2.5%).
- Existing $7.5M bridge loans from private equity investors subordinated to Comerica's first-priority lien.
- Proceeds for working capital and general corporate purposes; unused facility fee of 0.25% per annum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1054102/000149315221025744/0001493152-21-025744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1054102/000149315221025744/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-025744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer